OOIR: Observatory of International Research

Papers

(The median citation count of Current Opinion in Pulmonary Medicine is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)

Article	Citations
Spirometry, computed tomography, comorbidities, oxygen therapy and other topics in chronic obstructive pulmonary disease and an update on silicosis	46
Cardiac sarcoidosis and neurosarcoidosis – multidisciplinary approach for diagnosis	35
The persistent problem of persistent air-leaks: approach to management	34
The role of PET in the management of sarcoidosis	33
Home monitoring in asthma: towards digital twins	31
Bronchoscopic treatment of early-stage peripheral lung cancer	30
Thoracic empyema: aetiology, diagnosis, treatment, and prevention	28
Evolving nutritional needs, obesity, and overweight status in cystic fibrosis	25
Digital outcome measures in pulmonary clinical trials	23
Genetic background of pulmonary (vascular) diseases – how much is written in the codes?	22
Improving care in lung cancer surgery: a review of quality measures and evolving standards	22
Novel interventions on the tricuspid valve: how to consider the pulmonary circulation?	22
Implementation of digital home monitoring and management of respiratory disease	20
The role of chest computed tomography in the evaluation and management of chronic obstructive pulmonary disease	20
Considerations and clinical management of infections in sarcoidosis	19
Micro-RNA in obstructive sleep apnoea: biomarker of cardiovascular outcome?	19
Group 2 pulmonary hypertension: from diagnosis to treatment	19
Lung transplant referral considerations for individuals with cystic fibrosis	18
Editorial introductions	18
Asthma in pregnancy: a review of recent literature	17
The future of clinical trials in idiopathic pulmonary fibrosis	17
Casting light on the many facets of sarcoidosis	16
Elexacaftor–tezacaftor–ivacaftor use after solid organ transplant	16
An update of palliative care in lung transplantation with a focus on symptoms, quality of life and functional outcomes	16
Co-morbid insomnia and sleep apnea (COMISA): recent research and future directions	16

Management of patients with idiopathic pulmonary fibrosis and lung cancer: challenges in clinical practice	15
Progress for all: addressing disparities in sarcoidosis	15
Sarcoidosis and frailty: recognizing factors that foster holistic resilience	15
Cystic fibrosis liver disease in the post-modulator era	14
Tobacco treatment in the setting of lung cancer screening	14
Home monitoring of coronavirus disease 2019 patients in different phases of disease	14
Household air pollution and respiratory health in Africa: persistent risk and unchanged health burdens	14
What causes cough in pulmonary fibrosis, and how should we treat it?	14
Food for thought: optimal diet in patients with asthma and chronic obstructive pulmonary disease	14
The modern landscape of fertility, pregnancy, and parenthood in people with cystic fibrosis	14
Mechanisms relating to sleeping position to the endotypes of sleep disordered breathing	14
Utility of peak inspiratory flow measurement for dry powder inhaler use in chronic obstructive pulmonary disease	14
Digital inhalers for asthma management	14
Acute rejection post lung transplant	13
Imaging in peripheral bronchoscopy	13
Patterns of progression in non-IPF fibrotic interstitial lung disease	12
Editorial: Silicosis, asbestos-related diseases, war-site exposures and a variety of topics in chronic obstructive pulmonary disease	12
Neuropsychiatric adverse effects from CFTR modulators deserve a serious research effort	12
Editorial: Are we ready for prime time?	12
Mass gathering events and transmission of respiratory tract infections: updates pre and post COVID-19 lockdown	12
Novel insights in fibrotic pulmonary sarcoidosis	12
Effectiveness and safety of coronavirus disease 2019 vaccines	12
Chronic daily respiratory care needs in people with cystic fibrosis treated with highly effective cystic fibrosis transmembrane conductance regulator modulators	12
Exhaled breath analysis in interstitial lung disease	12
Pediatric interventional bronchoscopy: from early limitations to achievable opportunities	11
Interventional pulmonology: reflection on the past, perfecting the present and innovating for the future	11
Infection control in cystic fibrosis: evolving perspectives and challenges	11
Epigenetics and aging: relevance for sleep medicine	11
Telerehabilitation in pulmonary diseases	11
Multidisciplinary care in nonmalignant central airway obstruction	11
Altered pharmacology and toxicology during ageing: implications for lung disease	11
Role of extracorporeal membrane oxygenation and surgical embolectomy in acute pulmonary embolism	11
The association of preexisting severe asthma with COVID-19 outcomes	10
Editorial: ‘What is your occupation?’: historical snippets	10
Advancements in airway stents: a comprehensive update	10
The changing landscape of infections in the lung transplant recipient	10
Rigid versus flexible bronchoscopy in interventional pulmonology: perspective from the master clinicians	10
Ergonomics in bronchoscopy	10
Pulmonary rehabilitation in idiopathic pulmonary fibrosis	10
Adenotonsillectomy: the good, the bad and the unknown	10
Right ventricular assessment in pulmonary hypertension	10
Approach to the hospitalized patient with pulmonary arterial hypertension	9
Pulmonary embolism work-up in chronic obstructive pulmonary disease exacerbations: what is the best strategy for clinicians?	9
Long-term safety, durability of response, cessation and switching of biologics	9
Military deployment-related respiratory problems: an update	9
Prader–Willi syndrome: an update	9
Editorial introductions	8
Examining the impact of air pollution, climate change, and social determinants of health on asthma and environmental justice	8
Health inequities in the modulator era	8
Pulmonary vascular disease in chronic lung diseases: cause or comorbidity?	8

Methamphetamine-associated pulmonary arterial hypertension	8
Editorial introductions	8
Updates in the diagnosis and management of chronic thromboembolic disease	8
Lobar or sublobar resection of peripheral stage I non-small cell lung cancer	8
Editorial introductions	8
Bronchoscopic lung volume reduction in emphysema: a review	8
Recent advances predict a bright future for nebulizers	8
Pulmonary alveolar proteinosis – current and future therapeutical strategies	8
Artificial intelligence for the optimal management of community-acquired pneumonia	7
Bacteriophages for bronchiectasis: treatment of the future?	7
What is new in mediastinal staging?	7
Editorial introductions	7
Chronic obstructive pulmonary disease and cardiovascular disease: mechanistic links and implications for practice	7
Editorial: The role of ageing in pulmonary disease	7
Role of biomarkers in lung nodule evaluation	7
Clinical trials in pulmonary sarcoidosis; what is needed, what is happening and what is next?	7
Interstitial lung disease following coronavirus disease 2019	7
Whole lung and sequential bronchoscopic lavage for pulmonary alveolar proteinosis	7
Interrelationships between tuberculosis and chronic obstructive pulmonary disease	7
Burden, clinical features, and outcomes of post-tuberculosis chronic obstructive lung diseases	7
Revealing the pathogenic and ageing-related mechanisms of the enigmatic idiopathic pulmonary fibrosis (and chronic obstructive pulmonary disease)	7
Editorial introductions	7
Bronchoscopic interventions for chronic bronchitis	7
Environmental and occupational exposures in interstitial lung disease	6
Recent developments in occupational asthma	6
Indwelling pleural catheters for benign pleural effusions: a concise review	6
Interstitial lung disease in patients with anti-neutrophil cytoplasm antibody-associated vasculitis: an update on pathogenesis and treatment	6
Infection control in the bronchoscopy suite: effective reprocessing and disinfection of reusable bronchoscopes	6
‘Personalized medicine’: phenotyping pediatric obstructive sleep apnea	6
Cryoprobe biopsy versus mechanical biopsies in pulmonary diagnostics	6
Applications of artificial intelligence in computed tomography imaging for phenotyping pulmonary hypertension	6
Anesthetic considerations in interventional pulmonology	6
Risk stratification of pulmonary embolism	5
Editorial introductions	5
Editorial introduction	5
Lung infections due to emerging fungal pathogens	5
Initiation of home noninvasive ventilation in hypercapnic chronic obstructive pulmonary disease: when, where, and how?	5
Management of complicated parapneumonic effusions	5
Pulmonary Langerhans cell histiocytosis – an update on pathogenesis and treatment	5
Obstructive sleep apnea in the patient with atrial fibrillation: current knowledge and remaining uncertainties	5
Perioperative management of Obstructive Sleep Apnoea: Present themes and future directions	5
Percutaneous tracheostomy in the ICU: a review of the literature and recent updates	4
Emerging phenotypes of pulmonary hypertension associated with COPD: a field guide	4
Optimal long-term anticoagulation after acute pulmonary embolism: current state of the art and a look into the near future	4
The controversy over daylight saving time: evidence for and against	4
Sex differences in sleep and sleep-disordered breathing	4
Ageing with Interstitial lung disease: preserving health and well being	4
Diversity and disparity in the treatment and care of sarcoidosis	4
Pulmonary adverse events following immune checkpoint inhibitors	4
Whole lung lavage: considerations from the anesthesiology perspective	4
Predictors and markers of the cardiovascular impact of obstructive sleep apnoea	4
The treatment of sarcoidosis: translating the European respiratory guidelines into clinical practice	4
Glymphatic MRI techniques in sleep and neurodegenerative diseases	4
Lung transplantation: practical and important directions of care	4
Viral infections causing asthma exacerbations in the age of biologics and the COVID-19 pandemic	4
Epidemiology of advanced cystic fibrosis lung disease in the modulator era	4
Bedside to bench and back again-translational research in interventional pulmonology	4
Pulmonary hypertension in interstitial lung disease and in chronic obstructive pulmonary disease: different entities?	4
Vitamin D deficiency in chronic obstructive pulmonary disease	4
Progress and challenges in fungal lung disease in cystic fibrosis	4
Pregnancy and fertility in people with cystic fibrosis following lung transplantation	4